1. Home
  2. Shareholder and Investor Information
  3. Understanding RaQualia Pharma! RaQualia FAQ
  4. What About Dividends?

Shareholder and Investor Information

What About Dividends?

Our Dividend Policy

RaQualia was recently founded and has not paid any dividends to date.

RaQualia's primary goal is to provide growth opportunities for the company's shareholders via sustained productivity in new drug candidate compound research and development. Toward this end we will continue to invest in R&D activities for the foreseeable future. Nevertheless, we consider returning the company's profits to our shareholders to be a key management responsibility. In the event that we pay a dividend on surplus funds, we are considering a once-per-year disbursement at the end of the fiscal period. The decision regarding dividends will be made at the Shareholders' General Meeting. In addition, RaQualia has decided, pursuant to a resolution of the Board of Directors, the articles of incorporation provide for a mid-term dividend payment with the record date of June 30th of each year.

  • Previous
  • Next
  • FAQ

Page Top

Corporate Information
CEO Message
Company Overview
Vision, Management Principle and Culture
Quality Policy
Corporate Governance
Business Model
Origins of Our Corporate Name and Logo
Access
Press Release
Research & Development
Collaboration
Partnering in Research
What are Research Tools?
Research Tool Licensing
Product Information
Anidulafungin
Ziprasidone
Dalbavancin
Potassium-Competitive Acid Blocker
5-HT4 Partial Agonist
5-HT2B Antagonist
Motilin Receptor Agonist
Licensing Status
Shareholder and Investor Information
Vision, Management Principle and Culture
Corporate Governance
Outline of Securities Matters
IR Library
IR Calendar
Disclaimer
IR Related News
Understanding RaQualia Pharma! RaQualia FAQ
RaQualia's History
What does RaQualia Pharma do?
How Does RaQualia Earn Revenues?
What About Dividends?
What are RaQualia's strengths?
What Does the Future Hold for RaQualia Pharma?
Contributions to Society
Corporate Contributions
Contributions to the Community
Press Release
Topics